WO1989010415A1 - Methods for detecting nucleic acid sequences - Google Patents
Methods for detecting nucleic acid sequences Download PDFInfo
- Publication number
- WO1989010415A1 WO1989010415A1 PCT/US1989/001825 US8901825W WO8910415A1 WO 1989010415 A1 WO1989010415 A1 WO 1989010415A1 US 8901825 W US8901825 W US 8901825W WO 8910415 A1 WO8910415 A1 WO 8910415A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probe
- nucleic acid
- target
- acid molecule
- stranded
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Definitions
- Probe DNA is prepared by labelling radioactively specific DNA by nick translation, polynucleotide kinase, or some other polymerase type copy reaction using nucleotides labelled with 32 P. Once prepared, the probe DNA is permitted to hybridize with the bound target DNA. Hybridization is allowed to proceed at a suitable temperature, typically for several hours.
- the DNA probe will associate to form hybrid duplexes with any of the bound target DNA that has complementary base sequences. Extraneous material, including unbound probe DNA, is then washed away from the filter and the filter is then exposed to film sensitive to the radioactive label.
- European Patent Application Publication No. 0 067 597, (Bender et al.) published December 22, 1982 discloses oligonucleotides and a process for their preparation which comprises incorporating ribonucleotide units at specific locations in deoxyribonucleotide chains to provide predetermined cleavage sites which allow ease of chain cleavage. Although the products from their process are said to be useful for separating mixtures of nucleotide and polynucleotide products. Bender et al. do not teach a method for detecting target nucleic acid molecules based upon the amplification of probe fragments.
- U.S. Patent No. 4,358,535 discloses radioactively labeled nucleotide probes which are complementary to a target nucleic acid sequence of interest and a method of using these probes to detect the presence of a pathogen from which the target nucleic acid sequence is derived.
- the method comprises first fixing the target nucleic acid sequence to an inert support before hybridization with the probe. Next, the fixed nucleic acid is contacted with the radioactively labeled probe under hybridizing conditions, with hybridization taking place on the solid support. Then, the presence of the target nucleic acid sequence is determined by detecting the presence of any label on the inert support.
- a disadvantage of such a system is that the probe itself cannot be immobilized.
- the label molecules of the immobilized probe will be bound to the solid support regardless of whether the probe has hybridized with a target nucleic acid sequence. The result would not permit the detection of the presence of target nucleic acid.
- European Patent Application Publication No. 0 117 440 discloses non-radioactive chemically labeled polynucleotide probes and methods of using the probes. The methods disclosed are similar to the method of Falkow et al. in that the target nucleic acid sequence is fixed to a solid support before hybridization. Recently, other detection systems have been developed, such as fluorescent tags or color change enzyme systems. However, such systems have had significant problems with sensitivity and background levels (noise).
- U.S. Patent No. 4,362,867 discloses a hybrid nucleic acid construction which comprises two complementary deoxynucleotide sequences which are hybridized to form a double-stranded helical structure. Situated between and covalently bonded to the two deoxynucleotides is a ribonucleotide sequence. The construction forms a single unit, in which none of the nucleotide sequences repeat themselves.
- U.S. Patent No. 4,683,195 discloses a process for amplifying and detecting target nucleic acid sequences comprising treating separate complementary strands of the nucleic acid with a molar excess of two olignucleotide primers. By extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, the sequence so amplified is detected.
- a disadvantage of this process is the requirement of thermal cycling and the lack of constant temperature conditions.
- the present invention provides a method for detecting a target nucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target nucleic acid molecule.
- the present invention also provides a method for detecting a target deoxyribonucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target deoxyribonucleic acid molecule and a single-stranded nucleic acid probe having a ribonucleotide sequence complementary to the target deoxyribonucleic acid molecule which may be covalently bound at one or both of its termini to one or more deoxyribonucleotides which may or may not be complementary to the target deoxyribonucleic acid molecule under conditions which allow the probe and the target deoxyribonucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target deoxyribonucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe
- Figure 1 depicts the use of a nucleic acid probe as a self-amplifing and cycling construction in the method of the present invention for detecting target nucleic acid molecules.
- a pool of nucleic acid probes and a ribonuclease, e.g., RNase H, are reacted with a sample which contains a target nucleic acid molecule.
- the single-stranded nucleic acid probe is complementary to and in an amount greater than the target nucleic acid molecule.
- Double-stranded target-probe complexes are formed as the result of hybridization. RNase H nicks or excises out RNA sequences in hybridized double-stranded RNA-DNA.
- the remaining DNA probe fragments are "melted" off, i.e., become unhybridized, from the target molecule.
- the resulting single-stranded probe fragments are detectable by isotopic labelling or by the length of the probe fragment, i.e., by direct measurement.
- the probe fragments can be detected by coupling to fluorescent labels which have been initially placed on the nucleic acid probes or by ATP generation using single phosphorylated nucleotides, e.g., adenosine monophosphate, which have been formed. Additional probe molecules may react with the now free target molecules to complete the cycling sequence.
- RNase H does not nick or cleave unhybridized RNA.
- the present invention provides a method for detecting a target nucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target nucleic acid molecule.
- the invention further provides a method for detecting a target nucleic acid molecule which comprises repeating the above-described steps of (a), (b), and (c). In repeating these steps, the complementary single-stranded nucleic acid probe, which is in an amount greater, i.e., in molar excess, than the target molecule, is allowed to recycle, i.e., hybridize to the target molecule with other nucleic acid probes included in the reaction mixture.
- the nucleic acid probe which is useful in the practice of this invention comprises the structure:
- NA 1 and NA 2 are nucleic acid sequences, wherein R is an RNA sequence; and wherein n is an integer from about 1 to about 10.
- NA 1 and NA 2 in the nucleic acid probe independently comprise from about 0 to about 20 nucleotides, R comprises from about 1 to about 100 ribonucleotides, or more, and n is an integer from about 1 to about 10.
- NA 1 and NA 2 in the nucleic acid probe are DNA sequences.
- NA 1 and NA 2 in the nucleic acid probe are RNA sequences.
- the nucleic acid probe comprises a structure wherein NA 1 is either an RNA or DNA sequence, and NA 2 is either an RNA or DNA sequence.
- nicking the hybridized probe at predetermined RNA sequences is carried out with a double-stranded ribonuclease.
- ribonucleases nick or excise ribonucleic acid sequences from double-stranded DNA-RNA hybridized strands.
- An example of a ribonuclease useful in the practice of this invention is RNase H.
- Other ribonucleases and enzymes may be suitable to nick or excise RNA from RNA-DNA strands, such as Exo III and reverse transcriptase.
- the molecules of the present invention may have a detectable marker attached to one or more of the nucleic acid sequences, NA 1 or NA 2 .
- This marker is contemplated to be any molecule or reagent which is capable of being detected. Examples of such detectable molecules are radioisotopes, radiolabelled molecules, fluorescent molecules, fluorescent antibodies, enzymes, or chemiluminescent catalysts.
- Another suitable marker is a ligand capable of binding to specific proteins which have been tagged with an enzyme, fluorescent molecule or other detectable molecule.
- a suitable ligand is biotin, which will bind to avidin or streptavidin.
- the nucleic acid probe is immobilized on a solid support.
- the nucleic acid probe is labelled with a detectable marker.
- the R portion described above may also be properly termed a scissile linkage in language consistent with usage in U.S. Application Serial No. 805,279, filed December 5, 1985.
- a scissile linkage is capable of being cleaved or disrupted without cleaving or disrupting any nucleic acid sequence of the molecule itself or of the target nucleic acid molecule.
- a scissile linkage i.e., R
- R is any connecting chemical structure which joins two nucleic acid sequences and which is capable of being selectively cleaved without cleavage of the nucleic acid sequences to which it is joined.
- the scissile linkage may be a single bond or a multiple unit sequence.
- R denotes a ribonucleic acid (RNA) sequence.
- the unit NA 1 - - - R- - - NA 2 repeats. It is contemplated that the unit may be the same within each repeat or it may vary randomly or in a defined pattern.
- the unit may vary in that NA 1 or NA 2 or both may vary within each repeat.
- NA 1 or NA 2 may vary in that they have different nucleic acid sequences from one repeat unit to the next. This variation may occur randomly such that in every repeat unit, NA 1 and NA 2 , may also vary in that the number of bases of each may vary, either greater or less, from one repeat to the next. This variation may also occur randomly or in a pattern.
- the solid lines joining each unit are chemical bonds which may be either hydrogen bonds or covalent bonds.
- the repeat unit may also vary by variations in the scissile linkage, i.e., R, such that the sequence of ribonucleotides in R, the scissile linkage, will vary.
- the variation in the sequence of ribonucleotides in R, the scissile linkage may also be in a random or patterned fashion as discussed above.
- the repeat units may vary by any combination of the above-mentioned differences in NA 1 , NA 2 or the scissile linkage, i.e., R, and the variations may be random or patterned.
- nucleic acid probes whose lengths are relatively short, and therefore, highly specific to the target nucleic acid molecule.
- high gain - low noise detection of target nucleic acid molecules can be achieved.
- the total length of the nucleic acid probe may vary according to a number of factors including the nature of the target nucleic acid molecule to be detected, the construction of the nucleic acid probe, i.e., whether the probe is a DNA-RNA hybrid or is constructed of RNA sequences alone, and so forth.
- the probe is constructed of DNA and RNA sequences , it is important that the R portion or scissile linkage be accessible to nicking or excision in order that a DNA probe fragment remain hybridized to the target nucleic acid molecule.
- the R portion or scissile linkage be located between DNA sequences of from about 8 to about 10 nucleotides in order to allow the probe fragments to become single-stranded in accordance with the method provided by this invention.
- the nicking is facilitated especially when carried out with a double-stranded ribonuclease, such as RNase
- RNA probes constructed entirely of RNA sequences are particularly useful because first, they can be more easily produced enzymatically, and second, they have more cleavage sites which are accesible to nicking or cleaving by a nicking agent, such as the aforementioned ribonucleases. Thus, the straight RNA probes do not rely on a scissile linkage as in the DNA-RNA hybrid probes.
- the present invention also provides a method for detecting a target deoxyribonucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target deoxyribonucleic acid molecule and a single-stranded nucleic acid probe having a ribonucleotide sequence complementary to the target deoxyribonucleic acid molecule which may be covalently bound at one or both of its termini to one or more deoxyribonucleotides which may or may not be complementary to the target deoxyribonucleic acid molecule under conditions which allow the probe and the target deoxyribonucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within apredetermined sequence so as to form at least two probe fragments hybridized to the target deoxyribonucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe
- the invention provides a method for detecting a target deoxyribonucleic acid molecule which comprises repeating the above-described steps of (a), (b), and (c).
- the single stranded nucleic acid probe useful in method of this invention for detecting a target deoxyribonucleic acid comprises from about 10 to about 2000 ribonucleotides.
- ribonucleotides in such a nucleic acid probe may vary widely according to the target deoxyribonucleic acid, the degree of sensitivity required, and so forth.
- the target deoxyribonucleic acid molecule may have been converted to DNA sequences using methods well-known to those skilled in the art.
- nicking the hybridized probe in step (b) is carried out with a double-stranded ribonuclease.
- a ribonucleases may be RNase H.
- RNase H There are other enzymes having RNase H-like activity, such as Exo III and reverse transcriptase and so forth. These enzymes and others may be suitable, with or without modification to the methods described herein.
- the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater, i.e., in molar excess, than the target molecule are mixed together under hybridizing conditions which allow the probe and the target to hybridize to each other and form a double-stranded target-probe complex.
- nicking the hybridized probe in step (b) above can be carried out enzymatically, for example, by contacting the hybridized probe with an agent capable of nicking, i.e., excising out, predetermined sequences in the hybridized probe.
- predetermined sequences in the practice of this invention include the scissile linkages, i.e., R, or RNA sequences.
- the target nucleic acid molecule and the labelled complementary single-stranded nucleic acid probe, which is in excess to the target molecule are combined in a reaction mixture with an appropriate buffer.
- the reaction mixture so formed is incubated at a temperature, of from about 30o to about 45oC, optimally at about 37oC for from about 5 to about 30 minutes, up to about 60 minutes or how ever long a period of time is required to effect annealing.
- the reaction mixture which includes the hybridized target and probe is next combined with a nicking agent also at a temperature of from about 30 to 45oC, optimally at about 37oC for an additional amount of time.
- the additional amount of time may vary from about 5 to about 60 minutes although 30 minutes is sufficient in most cases.
- the cycling reaction which involves repeating the steps of hybridizing, nicking and causing single-stranded probe fragments to form takes place in a short period of time, e.g., on the order of milliseconds.
- the remaining hybridized probe fragments will become single-stranded as the result of the change in size of the hybridized probe sequences in the target-probe complex.
- a 20 mer (monomer) double-stranded DNA sequence will remain annealed or hybridized at 37oC.
- RNA 4-ribonucleotide
- DNA 8-deoxyribonucleotide
- ribonuclease e.g., RNase H or Exo III
- the remaining two 8-mer hybridized probe fragments will melt or fall off the target-probe complex.
- each paired nucleotide exhibits a melting point temperature of approximately 3o/base-pair.
- Identifying the probe fragments and thereby detecting the target nucleic acid molecule in step (c) may be performed using a number of methods.
- the method of identification and detection in step (c) will depend on the type of labelling or detectable marker which has been placed on the nucleic acid probe or which is generated in step (b) above.
- detection of the target nucleic acid molecule may be performed by coupling to a fluorescent label or by ATP generation.
- a probe is constructed entirely of ribonucleic acid (RNA) sequences
- the probe fragments which result from the nicking step (b) may range from mononucleotides to short olignucleotides.
- Such fragments will possess unique 5' phosphate groups which may be advantageously used in their detection.
- 5' adenosine monophosphate (5'-AMP) which may be fed into an enzymatic ATP generating system and subsequently linked to a luciferin-luciferase photometric read out system.
- the generated probe fragments may be detected directly using, for example, high performance liquid chromatography (HPLC).
- the methods of the present invention may be employed to obtain a high gain-low noise amplification system for detecting target nucleic acid molecules.
- the single-stranded nucleic acid probe whether constructed of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences, or ribonucleic acid (RNA) sequences alone, is completely stable to the action of certain doublestranded ribonucleases, e.g., RNase H.
- the RNA link which may or may not be a scissile linkage, becomes susceptible to digestion by the ribonuclease, e.g. , RNAse H.
- a 20 mer, (monomer) probe will form stable hybrids with a complementary target whereas an 8 mer (monomer) probe or probe fragment is easily melted off, i.e., becomes unhybridized, under the same conditions.
- the 20 mer probe after hybridization to the target nucleic acid molecule becomes cleavable and is cleaved by the ribonuclease, e.g., RNase H, resulting in pieces which readily melt off under the identical conditions of the primary hybridization in which the single-stranded nucleic acid probe became hybridized to the target molecule to form the double-stranded targetprobe complex.
- the ribonuclease e.g., RNase H
- the system described above will cycle (see Figure 1) and generate cleaved probe fragments, which may be detected using a number of wellknown methods, e.g., chemiluminescence, radio-isotopes.
- the primary amplifier i.e., the probe, is nucleic acid specific and will operate under constant conditions. High gain-first stage detection of 10 -20 moles of target with a radio-isotope label may be obtained.
- RNA probe made entirely of ribonucleic acid sequences In a situation where a straight RNA probe made entirely of ribonucleic acid sequences has been constructed, the resulting products after RNase H cycling will range from mononucleosides upwards to oligonucleotides depending on the size of the original probe. Each product, however, will have a 3'-OH terminus. These termini can be tailed with a suitable polymerase such as polynucleotide phosphorylase or poly A polymerase.
- a suitable polymerase such as polynucleotide phosphorylase or poly A polymerase.
- a useful adjunct to this approach is to have a biotin on the 5' terminus of the probe and a chain terminating nucleotide on the 3 ' terminus e.g., dideoxy. If the probe was designed so as to have a "U” at the 5' terminus and a "U” at the 3' terminus but with no other "U”s contained within the central region and if this probe was made by the action of T7 RNA polymerase on a suitable termplate, the following situation would hold:
- nucleoside triphosphate precursors for the T7 transcript (probe) polymerization are in the ratio of
- the resulting probe cannot be tailed unless cut by RNase H because of the 3' dideoxy U and the biotin can be used to separate the probe, which is now tailed with a fluorescent base or other detectable moiety, from non-biotinylated reactants.
- nucleic acid probe When the nucleic acid probe is constructed entirely of RNA sequences complementary to the target molecule and, therefore, not dependent on the scissile link, various modifications in the probe may be made which are fully contemplated by the invention described herein.
- a ribonucleic acid probe i.e., constructed entirely of RNA sequences
- Blocking may be effected by enzymatically producing a "tail" to the ribonucleic acid probe by attachment to a ligand, such as biotin, periodate oxidized ribonucleoside or an affinity tail, e.g., poly A (polymerase A) tailing.
- a ligand such as biotin, periodate oxidized ribonucleoside or an affinity tail, e.g., poly A (polymerase A) tailing.
- RNA probe may be used for affinity isolation and for signal generation.
- the 5' end of the RNA probe may likewise be optionally modified. For example, the
- RNA/DNA sequences which, in turn, may be attached to a ligand, as described above, e.g., biotin, periodate oxidized ribonucleoside or an affinity tail.
- ligand e.g., biotin, periodate oxidized ribonucleoside or an affinity tail.
- the 5' end could instead be linked to a signal generator such as a fluorescent base. This arrangment is shown below:
- - atttachment ligand e.g., biotin, periodate oxidized ribonucleoside, or affinity tail.
- - signal generator such as a fluorescent base
- the nonhomologous 5' tail in such an arrangment allows the ribonuclease, e.g., RNase H, to nick, i.e., excise or chew up, the homologous region of the RNA probe which has paired with the target.
- the 5' tail arrangement leaves a fragment available for polynucleoside phosphate (PNP) or polymerase A (poly A) tailing.
- PNP polynucleoside phosphate
- poly A polymerase A
- Such a tail may be used as an affinity tail to pull the signal out of ⁇ olution or as a further fragment to enhance detection. This arrangement is depicted below:
- the cycling nucleic acid probe may be used in immunoassays to detect antibodies or antigens.
- a nucleic acid sequence which could be a homopolymer, may be attached to either an antibody or antigen in competing or non-competing immunoassays:
- ELISA enzyme linked immunoassay
- Probe molecules useful in the detection methods of this invention have been constructed on a solid support medium (either silica gel or controlled pore glass) using either a hydrolysable linkage or a permanent (non-hydrolysable) linkage. Published chemical methods were used for this synthesis.
- MRC069 5'd(GGGTAACGCCAG)r(GGUUUU)d(CCCAGTCAC)3' - H.L.
- MRC070 5'd(GGGTAACGCCAG)r(GGUUUU)d(CCCAGTCAC)3' - P.L.
- Probe molecules 1-3 and 5-8 were shown to be cleavable at the ribonucleotides by a number of RNases including pancreatic RNase as well as by basic conditions (e.g., 0.5 M NaOH). Most general methods for cleavage by RNases and other routine procedures can be found in Maniatis et al. (Maniatis, T., E. F. Fritsch, and J. Sambrook, (1982), Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory).
- the mixture was incubated at 37oC for 40 minutes and then heat inactivated.
- the mixture was then passed through a Sephadex G-50 column using deionized water as an eluent. (Use Sanco transfer pipettes 15 mm ⁇ 7.5 mm as disposable columns. Plug with siliconized glass wool and pack with G-50 up to 12 mm.)
- Target 2 ⁇ g are diluted in 20 ⁇ l to give a concentration of 0.1 ⁇ g/ ⁇ l. This initial concentration is serially diluted 1:10 (10 ⁇ l in 90 ⁇ l distilled water) to the desired concentrations. For the cycling reaction, 10 ⁇ l (100 ng) were used for each reaction.
- Labelled Probe 2 ⁇ are diluted in 20 ⁇ l (0.1 ⁇ g/ ⁇ l). This initial concentration is diluted 1:10 (10 ⁇ l in 90 ⁇ l distilled water) to .01 ⁇ g/ ⁇ l. 10 ⁇ l (100 ng) were used for each reaction.
- each of the probes (9-22) were separately placed in the following reaction mixture: 10 ⁇ l (100 ng) of probe in distilled water(sterile) 3 ⁇ l 10X RNAse H buffer 7 ⁇ l distilled water 10 ⁇ l target DNA (1 ⁇ g to .01 fg)
Abstract
This invention provides a method for detecting a target nucleic acid molecule which comprises forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and identifying probe fragments, thereby detecting the target nucleic acid molecule. This invention also provides a method for detecting a target nucleic deoxyribonucleic acid molecule.
Description
METHODS FOR DETECTING NUCLEIC ACID SEQUENCES
This application is a continuation-in-part of U.S. Application Serial No. 805,279, filed December 5, 1985, the contents of which are hereby incorporated by reference.
Background of the Invention
Throughout this application, various patents and publi¬cations are references and citations provided for them. The disclosure of these patents and publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
Much of the disclosure of U.S. Application Serial No. 805,279 has also been published. See, e.g., European Patent Application No. 86116906.8, published August 7, 1987.
Current DNA probe methodology basically involves attaching target DNA to a nitrocellulose filter by bringing it into contact with the filter directly or via the Southern transfer technique from an agarose gel. The DNA is then denatured and the filters baked to ensure firm attachment. Generally, the preparation of the DNA and the running of the gels is a time consuming, costly process requiring a reasonably high technical skill level.
The next step is to prepare the probe DNA. Probe DNA is prepared by labelling radioactively specific DNA by nick translation, polynucleotide kinase, or some other polymerase type copy reaction using nucleotides labelled with 32P. Once prepared, the probe DNA is permitted to hybridize with the bound target DNA. Hybridization is allowed to proceed at a suitable temperature, typically for several hours. The DNA probe will associate to form hybrid duplexes with any of the bound target DNA that has complementary base sequences. Extraneous material, including unbound probe DNA, is then washed away from the filter and the filter is then exposed to film sensitive to the radioactive label. European Patent Application Publication No. 0 067 597, (Bender et al.) published December 22, 1982 discloses oligonucleotides and a process for their preparation which comprises incorporating ribonucleotide units at specific locations in deoxyribonucleotide chains to provide predetermined cleavage sites which allow ease of chain cleavage. Although the products from their process are said to be useful for separating mixtures of nucleotide and polynucleotide products. Bender et al. do not teach a method for detecting target nucleic acid molecules based upon the amplification of probe fragments.
International Patent Application No. WO 84/03520 (Malcolm et al.), published September 13, 1984, discloses a method of detecting nucleic acid sequences which utilizes tandem hybridization of a nucleic acid probe and an enzyme containing marker. The method involves contacting the probe with a sample containing a complementary target sequence under hybridizing conditions. Before or after hybridization with the target sequence,
the probe is attached by hybridization to an enzyme labelled marker polynucleotide which has a sequence complementary to a sequence on the probe.
U.S. Patent No. 4,358,535 (Falkow et al.) discloses radioactively labeled nucleotide probes which are complementary to a target nucleic acid sequence of interest and a method of using these probes to detect the presence of a pathogen from which the target nucleic acid sequence is derived. The method comprises first fixing the target nucleic acid sequence to an inert support before hybridization with the probe. Next, the fixed nucleic acid is contacted with the radioactively labeled probe under hybridizing conditions, with hybridization taking place on the solid support. Then, the presence of the target nucleic acid sequence is determined by detecting the presence of any label on the inert support. A disadvantage of such a system is that the probe itself cannot be immobilized. If the probe of Falkow et al. is immobilized, rather than the target nucleic acid sequence, then the label molecules of the immobilized probe will be bound to the solid support regardless of whether the probe has hybridized with a target nucleic acid sequence. The result would not permit the detection of the presence of target nucleic acid.
European Patent Application Publication No. 0 117 440 discloses non-radioactive chemically labeled polynucleotide probes and methods of using the probes. The methods disclosed are similar to the method of Falkow et al. in that the target nucleic acid sequence is fixed to a solid support before hybridization.
Recently, other detection systems have been developed, such as fluorescent tags or color change enzyme systems. However, such systems have had significant problems with sensitivity and background levels (noise).
U.S. Patent No. 4,362,867 (Paddock) discloses a hybrid nucleic acid construction which comprises two complementary deoxynucleotide sequences which are hybridized to form a double-stranded helical structure. Situated between and covalently bonded to the two deoxynucleotides is a ribonucleotide sequence. The construction forms a single unit, in which none of the nucleotide sequences repeat themselves.
U.S. Patent No. 4,683,195 (Mullis, et al.) discloses a process for amplifying and detecting target nucleic acid sequences comprising treating separate complementary strands of the nucleic acid with a molar excess of two olignucleotide primers. By extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, the sequence so amplified is detected. A disadvantage of this process is the requirement of thermal cycling and the lack of constant temperature conditions.
In U.S. Patent No. 4,683,194 (Saiki et al.), a method is disclosed for detecting the presence or absence of a specific site in a nucleic acid sequence using an oligonucleotide probe that is complementary to one strand of the nucleic acid sequence spanning the restriction site. Saiki et al. teach that their nucleic acid, i.e., oligonucleotide, probe, may be used as is or the sequence it contains can be amplified to increase sensitivity using the process disclosed in U.S.
Patent No. 4,683,202. Such an amplifying process suffers from the disadvantages inherent in U.S. Patent No. 4,683,195, discussed above.
Summary of the Invention
The present invention provides a method for detecting a target nucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target nucleic acid molecule.
The present invention also provides a method for detecting a target deoxyribonucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target deoxyribonucleic acid molecule and a single-stranded nucleic acid probe having a ribonucleotide sequence complementary to the target deoxyribonucleic acid molecule which may be covalently bound at one or both of its termini to one or more deoxyribonucleotides which may or may not be complementary to the target deoxyribonucleic acid molecule under conditions which allow the probe and the target deoxyribonucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target deoxyribonucleic
acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target deoxyribonucleic acid molecule.
Brief Description of the Figures
Figure 1 depicts the use of a nucleic acid probe as a self-amplifing and cycling construction in the method of the present invention for detecting target nucleic acid molecules. A pool of nucleic acid probes and a ribonuclease, e.g., RNase H, are reacted with a sample which contains a target nucleic acid molecule. The single-stranded nucleic acid probe is complementary to and in an amount greater than the target nucleic acid molecule. Double-stranded target-probe complexes are formed as the result of hybridization. RNase H nicks or excises out RNA sequences in hybridized double-stranded RNA-DNA.
As a consequence of such nicking, the remaining DNA probe fragments are "melted" off, i.e., become unhybridized, from the target molecule. The resulting single-stranded probe fragments are detectable by isotopic labelling or by the length of the probe fragment, i.e., by direct measurement. In practice, the probe fragments can be detected by coupling to fluorescent labels which have been initially placed on the nucleic acid probes or by ATP generation using single phosphorylated nucleotides, e.g., adenosine monophosphate, which have been formed. Additional probe molecules may react with the now free target molecules to complete the cycling sequence. RNase H does not nick or cleave unhybridized RNA. By using such a system of cycling, sensitivity of from about 10 -19 to about 10-20 molecules of target can be attained.
Detailed Description of the Invention
The present invention provides a method for detecting a target nucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target nucleic acid molecule.
In one embodiment, the invention further provides a method for detecting a target nucleic acid molecule which comprises repeating the above-described steps of (a), (b), and (c). In repeating these steps, the complementary single-stranded nucleic acid probe, which is in an amount greater, i.e., in molar excess, than the target molecule, is allowed to recycle, i.e., hybridize to the target molecule with other nucleic acid probes included in the reaction mixture.
The nucleic acid probe which is useful in the practice of this invention comprises the structure:
[NA1 - - -R- - -NA2] n
wherein NA1 and NA2 are nucleic acid sequences, wherein R is an RNA sequence; and wherein n is an integer from about 1 to about 10.
In one embodiment of this invention, NA1 and NA2 , in the nucleic acid probe independently comprise from about 0 to about 20 nucleotides, R comprises from about 1 to about 100 ribonucleotides, or more, and n is an integer from about 1 to about 10.
In another embodiment of this invention, NA1 and NA2 in the nucleic acid probe are DNA sequences. In a further embodiment, NA1 and NA2 in the nucleic acid probe are RNA sequences. In still yet another embodiment, the nucleic acid probe comprises a structure wherein NA1 is either an RNA or DNA sequence, and NA2 is either an RNA or DNA sequence.
In one embodiment, nicking the hybridized probe at predetermined RNA sequences is carried out with a double-stranded ribonuclease. Such ribonucleases nick or excise ribonucleic acid sequences from double-stranded DNA-RNA hybridized strands. An example of a ribonuclease useful in the practice of this invention is RNase H. Other ribonucleases and enzymes may be suitable to nick or excise RNA from RNA-DNA strands, such as Exo III and reverse transcriptase.
The molecules of the present invention may have a detectable marker attached to one or more of the nucleic acid sequences, NA1 or NA2. This marker is contemplated to be any molecule or reagent which is capable of being detected. Examples of such detectable molecules are radioisotopes, radiolabelled molecules, fluorescent molecules, fluorescent antibodies, enzymes, or
chemiluminescent catalysts. Another suitable marker is a ligand capable of binding to specific proteins which have been tagged with an enzyme, fluorescent molecule or other detectable molecule. One example of a suitable ligand is biotin, which will bind to avidin or streptavidin.
In one embodiment of this invention, the nucleic acid probe is immobilized on a solid support. In another, the nucleic acid probe is labelled with a detectable marker.
When the nucleic acid sequences, NA1 and NA2 are DNA, the R portion described above may also be properly termed a scissile linkage in language consistent with usage in U.S. Application Serial No. 805,279, filed December 5, 1985. Such a linkage is capable of being cleaved or disrupted without cleaving or disrupting any nucleic acid sequence of the molecule itself or of the target nucleic acid molecule. As used herein, such a scissile linkage, i.e., R, is any connecting chemical structure which joins two nucleic acid sequences and which is capable of being selectively cleaved without cleavage of the nucleic acid sequences to which it is joined. The scissile linkage may be a single bond or a multiple unit sequence. As used herein, R denotes a ribonucleic acid (RNA) sequence.
In molecules useful as probes in the present invention in which n is greater than one , the unit NA1- - - R- - - NA2 repeats. It is contemplated that the unit may be the same within each repeat or it may vary randomly or in a defined pattern. The unit may vary in that NA1 or NA2 or both may vary within each repeat. NA1 or NA2 may vary in that they have different nucleic acid sequences
from one repeat unit to the next. This variation may occur randomly such that in every repeat unit, NA1 and NA2, may also vary in that the number of bases of each may vary, either greater or less, from one repeat to the next. This variation may also occur randomly or in a pattern. An example of a random variation where n=3 and both NA. and NA- vary is:
NA1- - - R- - - NA2- - - NA1' - - - R- - - NA2 ' - - - NA1 "- - - R- - - NA2"
An example of a patterned variation where n*=4 and both NA1 and NA2 vary is:
NA1- - - R- - - NA2- - - NA1 ' - - -R- - - NA2 ' - - - NA1- - - R- - - NA2
NA1 ' - - - R- - - NA2 '
In both of the above examples, the solid lines joining each unit are chemical bonds which may be either hydrogen bonds or covalent bonds.
The repeat unit may also vary by variations in the scissile linkage, i.e., R, such that the sequence of ribonucleotides in R, the scissile linkage, will vary. The variation in the sequence of ribonucleotides in R, the scissile linkage, may also be in a random or patterned fashion as discussed above. Also, the repeat units may vary by any combination of the above-mentioned differences in NA1, NA2 or the scissile linkage, i.e., R, and the variations may be random or patterned.
Those skilled in this art will readily appreciate that best results may be achieved with the use of nucleic acid probes whose lengths are relatively short, and therefore, highly specific to the target nucleic acid molecule. By limiting rather than increasing the total
number of nucleotides in the complementary nucleic acid probe, high gain - low noise detection of target nucleic acid molecules can be achieved.
Those skilled in this art will readily appreciate that the total length of the nucleic acid probe may vary according to a number of factors including the nature of the target nucleic acid molecule to be detected, the construction of the nucleic acid probe, i.e., whether the probe is a DNA-RNA hybrid or is constructed of RNA sequences alone, and so forth. When the probe is constructed of DNA and RNA sequences , it is important that the R portion or scissile linkage be accessible to nicking or excision in order that a DNA probe fragment remain hybridized to the target nucleic acid molecule. In this regard it is advantageous though not required that the R portion or scissile linkage be located between DNA sequences of from about 8 to about 10 nucleotides in order to allow the probe fragments to become single-stranded in accordance with the method provided by this invention.
When the probe is constructed entirely of RNA sequences, the nicking is facilitated especially when carried out with a double-stranded ribonuclease, such as RNase
H or Exo III. Straight RNA probes constructed entirely of RNA sequences are particularly useful because first, they can be more easily produced enzymatically, and second, they have more cleavage sites which are accesible to nicking or cleaving by a nicking agent, such as the aforementioned ribonucleases. Thus, the straight RNA probes do not rely on a scissile linkage as in the DNA-RNA hybrid probes.
The present invention also provides a method for detecting a target deoxyribonucleic acid molecule which comprises: (a) forming a reaction mixture which includes the target deoxyribonucleic acid molecule and a single-stranded nucleic acid probe having a ribonucleotide sequence complementary to the target deoxyribonucleic acid molecule which may be covalently bound at one or both of its termini to one or more deoxyribonucleotides which may or may not be complementary to the target deoxyribonucleic acid molecule under conditions which allow the probe and the target deoxyribonucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex; (b) nicking the hybridized probe at least once within apredetermined sequence so as to form at least two probe fragments hybridized to the target deoxyribonucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and (c) identifying probe fragments, thereby detecting the target deoxyribonucleic acid molecule.
In one embodiment, the invention provides a method for detecting a target deoxyribonucleic acid molecule which comprises repeating the above-described steps of (a), (b), and (c).
The single stranded nucleic acid probe useful in method of this invention for detecting a target deoxyribonucleic acid comprises from about 10 to about 2000 ribonucleotides. Those skilled in the art will readily appreciate that the number of ribonucleotides in such a nucleic acid probe may vary widely according to the target deoxyribonucleic acid, the degree of sensitivity required, and so forth. In forming the reaction
mixture in step (a) the target deoxyribonucleic acid molecule may have been converted to DNA sequences using methods well-known to those skilled in the art.
In a further embodiment of this invention, nicking the hybridized probe in step (b) is carried out with a double-stranded ribonuclease. In still yet a further embodiment such a ribonucleases may be RNase H. There are other enzymes having RNase H-like activity, such as Exo III and reverse transcriptase and so forth. These enzymes and others may be suitable, with or without modification to the methods described herein.
In forming the reaction mixture in step (a) above, the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater, i.e., in molar excess, than the target molecule, are mixed together under hybridizing conditions which allow the probe and the target to hybridize to each other and form a double-stranded target-probe complex.
Nicking the hybridized probe in step (b) above can be carried out enzymatically, for example, by contacting the hybridized probe with an agent capable of nicking, i.e., excising out, predetermined sequences in the hybridized probe. Such predetermined sequences in the practice of this invention include the scissile linkages, i.e., R, or RNA sequences.
Typically the target nucleic acid molecule and the labelled complementary single-stranded nucleic acid probe, which is in excess to the target molecule, are combined in a reaction mixture with an appropriate buffer. The reaction mixture so formed is incubated at
a temperature, of from about 30º to about 45ºC, optimally at about 37ºC for from about 5 to about 30 minutes, up to about 60 minutes or how ever long a period of time is required to effect annealing.
The reaction mixture which includes the hybridized target and probe is next combined with a nicking agent also at a temperature of from about 30 to 45ºC, optimally at about 37ºC for an additional amount of time. The additional amount of time may vary from about 5 to about 60 minutes although 30 minutes is sufficient in most cases. The cycling reaction which involves repeating the steps of hybridizing, nicking and causing single-stranded probe fragments to form takes place in a short period of time, e.g., on the order of milliseconds.
By nicking the hybridized double-stranded target-probe complex at least once within a predetermined sequence, e.g., in R or the scissile linkage, so as to form at least two probe fragments hybridized to the target nucleic acid molecule, the remaining hybridized probe fragments will become single-stranded as the result of the change in size of the hybridized probe sequences in the target-probe complex. For example, a 20 mer (monomer) double-stranded DNA sequence will remain annealed or hybridized at 37ºC. After nicking, assuming that an intervening 4-ribonucleotide (RNA) base sequence between two 8-deoxyribonucleotide (DNA) base sequences is excised by a ribonuclease, e.g., RNase H or Exo III, the remaining two 8-mer hybridized probe fragments will melt or fall off the target-probe complex. These single-stranded probe fragments may then be identified using well-known methods, thereby detecting the target nucleic acid molecule.
A=T and G=C base-pairs exhibit T s of approximately 2º/base-pair and 4º/base pair, for short olgomers respectively. On the average, assuming equal ratios of A-T and G-C base pairs in a hybridized target-probe complex, each paired nucleotide exhibits a melting point temperature of approximately 3º/base-pair.
Identifying the probe fragments and thereby detecting the target nucleic acid molecule in step (c) may be performed using a number of methods. The method of identification and detection in step (c) will depend on the type of labelling or detectable marker which has been placed on the nucleic acid probe or which is generated in step (b) above. For example, detection of the target nucleic acid molecule may be performed by coupling to a fluorescent label or by ATP generation. Where, for example, a probe is constructed entirely of ribonucleic acid (RNA) sequences, the probe fragments which result from the nicking step (b) may range from mononucleotides to short olignucleotides. Such fragments will possess unique 5' phosphate groups which may be advantageously used in their detection. Among such fragments are 5' adenosine monophosphate (5'-AMP) which may be fed into an enzymatic ATP generating system and subsequently linked to a luciferin-luciferase photometric read out system. As an alternative method of detection, the generated probe fragments may be detected directly using, for example, high performance liquid chromatography (HPLC).
Those skilled in the art will further appreciate that the methods of the present invention may be employed to obtain a high gain-low noise amplification system for detecting target nucleic acid molecules. The single-stranded nucleic acid probe, whether constructed of
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences, or ribonucleic acid (RNA) sequences alone, is completely stable to the action of certain doublestranded ribonucleases, e.g., RNase H. When such a probe is hybridized to a target nucleic acid molecule, the RNA link, which may or may not be a scissile linkage, becomes susceptible to digestion by the ribonuclease, e.g. , RNAse H.
Taking as an example for illustrative purposes only, a probe of an overall length of 20 nucleotides of which the first eight and last eight nucleotides are deoxyribonucleotides and the intervening four nucleotides are ribonucleotides, the amplifying aspect of the methods of this invention may be explained. A 20 mer, (monomer) probe will form stable hybrids with a complementary target whereas an 8 mer (monomer) probe or probe fragment is easily melted off, i.e., becomes unhybridized, under the same conditions. Consequently, the 20 mer probe after hybridization to the target nucleic acid molecule, becomes cleavable and is cleaved by the ribonuclease, e.g., RNase H, resulting in pieces which readily melt off under the identical conditions of the primary hybridization in which the single-stranded nucleic acid probe became hybridized to the target molecule to form the double-stranded targetprobe complex.
If hybridization is carried out with a customary excess of probe and in the presence of a suitable ribonuclease, e.g., RNase H, the system described above will cycle (see Figure 1) and generate cleaved probe fragments, which may be detected using a number of wellknown methods, e.g., chemiluminescence, radio-isotopes. The primary amplifier, i.e., the probe, is nucleic acid
specific and will operate under constant conditions. High gain-first stage detection of 10-20 moles of target with a radio-isotope label may be obtained.
In a situation where a straight RNA probe made entirely of ribonucleic acid sequences has been constructed, the resulting products after RNase H cycling will range from mononucleosides upwards to oligonucleotides depending on the size of the original probe. Each product, however, will have a 3'-OH terminus. These termini can be tailed with a suitable polymerase such as polynucleotide phosphorylase or poly A polymerase.
A useful adjunct to this approach is to have a biotin on the 5' terminus of the probe and a chain terminating nucleotide on the 3 ' terminus e.g., dideoxy. If the probe was designed so as to have a "U" at the 5' terminus and a "U" at the 3' terminus but with no other "U"s contained within the central region and if this probe was made by the action of T7 RNA polymerase on a suitable termplate, the following situation would hold:
If the nucleoside triphosphate precursors for the T7 transcript (probe) polymerization are in the ratio of
100 ATP
100 CTP
100 GTP 100 Dideoxy UTP
1 Biotinylated UTP then virtually every probe transcript will begin with biotinylated U and end with dideoxy U. Polymerization will fail if a dideoxy U is selected for the first base. Thus a start with biotinylated UTP is mandatory. Because, with excess template, almost all the biotinylated U will be used for starting and because the dideoxy U is 100 times in excess over the biotinylated U, the 3' U will almost always be a dideoxy U. Hence, detection goals may be obtained via an enzymatic synthesis. The resulting probe cannot be tailed unless cut by RNase H because of the 3' dideoxy U and the biotin can be used to separate the probe, which is now tailed with a fluorescent base or other detectable moiety, from non-biotinylated reactants.
When the nucleic acid probe is constructed entirely of RNA sequences complementary to the target molecule and, therefore, not dependent on the scissile link, various modifications in the probe may be made which are fully contemplated by the invention described herein.
For example, a ribonucleic acid probe, i.e., constructed entirely of RNA sequences, may be synthesized and its 3' hydroxyl end optionally blocked. Blocking may be effected by enzymatically producing a "tail" to the ribonucleic acid probe by attachment to a ligand, such as biotin, periodate oxidized ribonucleoside or an affinity tail, e.g., poly A (polymerase A) tailing. The
"tail" to the probe may be used for affinity isolation and for signal generation. The 5' end of the RNA probe may likewise be optionally modified. For example, the
5' end may be extended with non-homologous RNA/DNA sequences which, in turn, may be attached to a ligand, as described above, e.g., biotin, periodate oxidized
ribonucleoside or an affinity tail. In this particular embodiment, the 5' end could instead be linked to a signal generator such as a fluorescent base. This arrangment is shown below:
- atttachment ligand, e.g., biotin, periodate oxidized ribonucleoside, or affinity tail.
- signal generator such as a fluorescent base
The nonhomologous 5' tail in such an arrangment allows the ribonuclease, e.g., RNase H, to nick, i.e., excise or chew up, the homologous region of the RNA probe which has paired with the target. Thus the 5' tail arrangement leaves a fragment available for polynucleoside phosphate (PNP) or polymerase A (poly A) tailing. Such a tail may be used as an affinity tail to pull the signal out of βolution or as a further fragment to enhance detection. This arrangement is depicted below:
In another feature of this invention, the cycling nucleic acid probe may be used in immunoassays to detect antibodies or antigens. In this situation, a nucleic acid sequence, which could be a homopolymer, may be attached to either an antibody or antigen in competing or non-competing immunoassays:
or
An example of a competing immunoassay is the enzyme linked immunoassay (ELISA)
This invention is illustrated in the examples which follow. These examples are set forth to aid in the understanding of the invention but are not intended to, and should not be construed to, limit in any way the invention as set forth in the claims which follow thereafter.
EXAMPLE 1
CONSTRUCTION OF SCISSILE LINK PROBES
Probe molecules useful in the detection methods of this invention have been constructed on a solid support medium (either silica gel or controlled pore glass) using either a hydrolysable linkage or a permanent (non-hydrolysable) linkage. Published chemical methods were used for this synthesis. (Alvarado-Urbina, G., G.M. Sathe, W. C. Liu, M. F. Gillan, P.D. Duck, R. Bender, and K.K. Ogilvie (1981), Automated Synthesis of Gene Fragments, Science 214: 270-274; Roberts, D.M., R. Crea, M. Malecha, G. Alvarado-Urbina, R.H. Chiarello, and D.M. Watterson (1985), Chemical Synthesis and Expression of a Calmodulin gene designed for a Site-Specific Mutagenesis, Biochemistry, in press; Van Boom, J.H., and C.T. Wreesman (1984), Chemical Synthesis of Small Oligoribonucleotides in Solution, In Oligonucleotide Synthesis--A Practical Approach, pp. 153-183, Ed. M. J. Gait, IRL Press). Standard protected deoxynucleoside monomers were obtained from commercial sources whereas protected deoxyuridme and the ribonucleoside whereas protected deoxyuridine and the ribonucleoside monomers were prepared using published procedures. (Ti, G.S., B.L. Gaffney, and R.A. Jones (1982), Transient Protection: Efficient One Flask Synthesis of Protected Nucleosides, J. AM. Chem. Soc. 104:
1316). Synthesis was performed with a BIOLOGICALS automated synthesizer using a cycle time of 10 minutes for each DNA condensation and 12 minutes for each RNA condensation.
The following probe constructions were used in various test systems.
SCISSILE LINK PROBES
P. L. = Permanent Linkage to Solid Support H. L. = Hydrolysable Linkage to Solid Support
1. MRC046 : 5 'd (TTTTTTTTTT) r (UUTJUUU) d (TTTTTTTTTTT) 3 ' - P. L.
2. MRC059 :
5'd(TTTTTTTTTT)r(UUUU)d(TTTTTTTTTTTT)3' - H.L.
3. HRC060:
5'd(TTTTTTTTTTTT)R(UUUU)D(TTTTTTTTTT)3' - H.L.
4. MRC064:
5'd(TTTTTTTTTTTT)d(UUUUUUUU)d(TTTTTTTTTT)3' - H.L.
5. MRC068:
5'd(TTTTTTTTTTTTTT)d(uuuuuuuu)d(TTTTTTTTTT)3' - H.L.
6. MRC069: 5'd(GGGTAACGCCAG)r(GGUUUU)d(CCCAGTCAC)3' - H.L.
7. MRC070: 5'd(GGGTAACGCCAG)r(GGUUUU)d(CCCAGTCAC)3' - P.L.
8. MRC071:
5'd (TTTTTTTTTTTTTTT) r(uu) d(TTTTTTTTTT) 3 ' - H . L.
Probe molecules 1-3 and 5-8 were shown to be cleavable at the ribonucleotides by a number of RNases including pancreatic RNase as well as by basic conditions (e.g., 0.5 M NaOH). Most general methods for cleavage by RNases and other routine procedures can be found in
Maniatis et al. (Maniatis, T., E. F. Fritsch, and J. Sambrook, (1982), Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory).
EXAMPLE 2
The following probe constructions* were used in accordance with the methods provided by this invention:
#261 (9) 5' C C A G G G T T U U C C C A G T C A C G 3'
#268 (10) 5' A C G C C A G G G T T T T C C c a g T C A
C G A C 3'
#271 (11) 5' C A G G G T T u g a u c a G T C A C G A C
3'
#276 (12) 5' T A C A A A C A C C C C C A A T A T T G 3'
#284 (13) 5' T A G A C T T T g c a a C T C T T G G T 3'
#286 (14) 5' a c a a a c a c c c c c a a u a u u 3'
#287 (15) 5' C C A G g g u T T T C c c a G T C A 3'
#293 (16) Biotin ~ 5' C C A G G G T T u u c c C A G T C
A C G 3' #296 (17) 5' T T T T T T T g g g g T T T T T T T 3' #300 (18) 5' T T T T T T T C C C C T T T T T T T 3' #308 (19) 5' T A G C T T a a u a a T T C G A T 3' #311 (20) 5' C A G T G C a a c a a A G T G C G #313 (21) 5' G A C T G C a c a c a A G T G C A #316 (22) 5' G T T T A A A g u c u g C C C A A G A 3' * Upper case letters are DNA. Lower caεe letterε are RNA. Some of the above sequences were M-13 phage complements but all had synthetic DNA target complements constructed for them.
Kination and Cycling with RNase H.
2μg of the electropurified probes (9-22) were placed in a mixture containing the following:
2 μg probe 2 μl
4 μMATP 4 μl
10X KB (Kinase buffer) 5 μl dH2O 32 μl P 32 ATP 2 μl = 20 uCi
Polynucleotide Kinase 5 μl = 5 units
The mixture was incubated at 37ºC for 40 minutes and then heat inactivated. The mixture was then passed through a Sephadex G-50 column using deionized water as an eluent. (Use Sanco transfer pipettes 15 mm × 7.5 mm as disposable columns. Plug with siliconized glass wool and pack with G-50 up to 12 mm.)
500 μl fractions were collected into 1.5 ml Eppendorf tubes and the first peak was selected (usually tubes 3-5). The selected fractions were dried in a speed vac concentrator. The tubes were pooled together to give a final concentration of 0.1 μg/μl in sterile water.
Dilution for Cycling Reaction
Target: 2 μg are diluted in 20 μl to give a concentration of 0.1 μg/μl. This initial concentration is serially diluted 1:10 (10 μl in 90 μl distilled water) to the desired concentrations. For the cycling reaction, 10 μl (100 ng) were used for each reaction.
Labelled Probe: 2μare diluted in 20 μl (0.1 μg/μl). This initial concentration is diluted 1:10 (10 μl in 90 μl distilled water) to .01 μg/μl. 10 μl (100 ng) were used for each reaction.
Cycling Reaction
For the cycling reaction, each of the probes (9-22) were separately placed in the following reaction mixture:
10 μl (100 ng) of probe in distilled water(sterile) 3 μl 10X RNAse H buffer 7 μl distilled water 10 μl target DNA (1 μg to .01 fg)
The 30 μl reaction mixture was incubated at 65ºC for 10 minutes and at 37ºC for 30 minutes. From each 30 μl reaction mixture, the following were taken: C1 (RNAse H) control - 5 μl = 16.7 ng probe
C2 (30 min. time) control - 5 μl = 16.7 ng probe To the remaining 20 μl of reaction mixture, the following were added with Control C1 above:
1 μl RNase H at 0 minutes time 1 μl RNase H at 10 minutes time
1 μl RNase H at 20 minutes time. The reaction mixture was incubated for 30 minutes. Each reaction was loaded with the same amount of probe as the control plus an equal amount of formamide dye on a 0.8 mm 20% acrylamide/7 M urea gel at 800 volts with a heating plate.
Claims
1. A method for detecting a target nucleic acid molecule which comprises:
(a) forming a reaction mixture which includes the target nucleic acid molecule and an amount of a complementary single-stranded nucleic acid probe which is greater than the target molecule, under conditions which allow the probe and the target nucleic acid molecule to hybridize to each other and form a double stranded target-probe complex;
(b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target nucleic acid molecule, resulting in the probe fragments to become single-standed and allowing the target nucleic acid molecule to become hybridized to another probe; and
(c) identifying probe fragments, thereby detecting the target nucleic acid molecule.
2. A method of claim 1, wherein the steps of (a), (b) and (c) are repeated.
3. A method of claim 1, wherein the single-stranded nucleic acid probe comprises the structure:
[NA1- - - R- - -NA2 ] n
wherein NA. and NA2 are nucleic acid sequences,
wherein R is an RNA sequence; and wherein n is an integer from about 1 to about 10.
4. A method of claim 3, wherein NA1 and NA2 independently comprise from about 0 to about 20 nucleotides, R comprises from about 1 to about 100 ribonucleotides and n is an integer from about 1 to about 10.
5. A method of claim 3, wherein NA1 and NA2 are DNA sequences.
6. A method of claim 3, wherein NA1 and NA2 are RNA sequences.
7. A method of claim 3, wherein NA is either an RNA or DNA sequence, and NA2 is either an RNA or DNA sequence.
8. A method of claim 3, wherein the step of nicking is carried out with a double stranded ribonuclease.
9. A method of claim 8, wherein the ribonuclease is RNase H.
10. A method of claim 8, wherein the ribonuclease is Exo III.
11. A method of claim 1, wherein the nucleic acid probe is labelled with a detectable marker.
12. A method of claim 1, wherein the nucleic acid probe is immobilized on a solid support.
13. A method for detecting a target deoxyribonucleic acid molecule which comprises:
(a) forming a reaction mixture which includes the target deoxyribonucleic acid molecule and a single-stranded nucleic acid probe having a ribonucleotide sequence complementary to the target deoxyribonucleic acid molecule which may be covalently bound at one or both of its termini to one or more deoxyribonucleotides which may or may not be complementary to the target deoxyribonucleic acid molecule under conditions which allow the probe and the target deoxyribonucleic acid molecule to hybridize to each other and form a double-stranded target-probe complex;
(b) nicking the hybridized probe at least once within a predetermined sequence so as to form at least two probe fragments hybridized to the target deoxyribonucleic acid molecule, resulting in the probe fragments to become single-stranded and allowing the target nucleic acid molecule to become hybridized to another probe; and
(c) identifying probe fragments, thereby detecting the target deoxyribonucleic acid molecule.
14. A method of claim 13, wherein the steps of
(a), (b) and (c) are repeated.
15. A method of claim 13, wherein the single- stranded nucleic acid probe comprises from about 10 to about 2000 ribonucleotides.
16. A method of claim 13, wherein the step of nicking is carried out with a double-stranded ribonuclease.
17. A method of claim 16, wherein the ribonuclease is RNase H.
18. A method of claim 16, wherein the ribonuclease is Exo III.
19. A method of claim 13, wherein the nucleic acid probe is labelled with a detectable marker.
20. A method of claim 13, wherein the nucleic acid probe is immobilized on a solid support.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK665889A DK665889A (en) | 1988-04-29 | 1989-12-22 | METHOD OF DETECTING NUCLEIC ACID SEQUENCES |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US187,814 | 1988-04-29 | ||
US07/187,814 US5011769A (en) | 1985-12-05 | 1988-04-29 | Methods for detecting nucleic acid sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1989010415A1 true WO1989010415A1 (en) | 1989-11-02 |
Family
ID=22690579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/001825 WO1989010415A1 (en) | 1988-04-29 | 1989-04-28 | Methods for detecting nucleic acid sequences |
Country Status (6)
Country | Link |
---|---|
US (1) | US5011769A (en) |
EP (1) | EP0365663A4 (en) |
JP (1) | JP2839608B2 (en) |
AU (1) | AU3569789A (en) |
CA (1) | CA1341495C (en) |
WO (1) | WO1989010415A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0439182A2 (en) * | 1990-01-26 | 1991-07-31 | Abbott Laboratories | Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions |
EP0455517A1 (en) * | 1990-05-04 | 1991-11-06 | Oncor, Inc. | Restriction amplification assay |
WO1991017264A1 (en) * | 1990-05-02 | 1991-11-14 | Imperial Chemical Industries Plc | Assay for specific nucleic acid sequences |
EP0578138A2 (en) * | 1992-07-10 | 1994-01-12 | Hitachi, Ltd. | Gene-detecting method |
FR2697851A1 (en) * | 1992-11-10 | 1994-05-13 | Bio Merieux | Detecting target nucleic acid by restriction enzyme amplification |
EP0599338A2 (en) * | 1992-11-27 | 1994-06-01 | Canon Kabushiki Kaisha | Method for detecting target nucleic acid |
WO1995005480A2 (en) * | 1993-08-18 | 1995-02-23 | Id Biomedical Corporation | Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules |
WO1995006756A2 (en) * | 1993-09-03 | 1995-03-09 | Abbott Laboratories | OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
WO1995014106A2 (en) * | 1993-11-17 | 1995-05-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
EP0711361A1 (en) * | 1993-06-04 | 1996-05-15 | Third Wave Technologies, Inc. | 5' nucleases derived from thermostable dna polymerase |
WO1996020287A2 (en) * | 1994-12-23 | 1996-07-04 | Behringwerke Aktiengesellschaft | Detection of nucleic acids by target-catalyzed product formation |
US5624798A (en) * | 1992-12-21 | 1997-04-29 | Canon Kabushiki Kaisha | Detection method of nucleic acid by use of fluorescent pyrylium stain in intercalation into nucleic acids |
US5670315A (en) * | 1993-09-13 | 1997-09-23 | Canon Kabushiki Kaisha | Nucleic acid determination employing pyryilium dye |
US5783392A (en) * | 1994-11-23 | 1998-07-21 | Boehringer Mannheim Gmbh | Method for the particularly sensitive detection of nucleic acids |
US5939256A (en) * | 1992-11-27 | 1999-08-17 | Canon Kabushiki Kaisha | Detection of nucleic acid hybrid variation which interacts with double helix or with second reagent through double helix by charge transfer and probe for hybridizing with target nucleic acid |
US6001610A (en) * | 1994-11-23 | 1999-12-14 | Roche Diagnostics, Gmbh | Method for the particularly sensitive detection of nucleic acids |
US6124342A (en) * | 1993-12-27 | 2000-09-26 | Canon Kk | Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
US6156506A (en) * | 1994-05-26 | 2000-12-05 | Canon Kabushiki Kaisha | Method for detecting a target substance in a sample, utilizing pyrylium compound |
US6297008B1 (en) | 1996-10-03 | 2001-10-02 | Canon Kabushiki Kaisha | Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
JP2002223761A (en) * | 2001-01-30 | 2002-08-13 | Nipro Corp | Method for detecting target nucleic acid and reagent therefor |
US6884586B2 (en) | 2001-07-15 | 2005-04-26 | Keck Graduate Institute | Methylation analysis using nicking agents |
US7112423B2 (en) | 2001-07-15 | 2006-09-26 | Keck Graduate Institute | Nucleic acid amplification using nicking agents |
US7135291B2 (en) | 2001-02-15 | 2006-11-14 | Takara Bio Inc. | Method of detecting nucleotide polymorphism |
WO2009085704A3 (en) * | 2007-12-26 | 2009-09-03 | Gen-Probe Incorporated | Compositions and methods to detect candida albicans nucleic acid |
WO2013154138A1 (en) | 2012-04-11 | 2013-10-17 | 富士レビオ株式会社 | Method for detecting target nucleic acid using molecular beacon-type probe |
US9562258B2 (en) | 2005-02-15 | 2017-02-07 | Georgetown University | Sequence-specific detection of nucleotide sequences |
EP3907298A4 (en) * | 2020-02-28 | 2022-03-09 | Nuribio., Ltd. | Single nucleic acid for real-time detection of genetic variation of single target gene, and detection method using same |
Families Citing this family (228)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714380A (en) | 1986-10-23 | 1998-02-03 | Amoco Corporation | Closed vessel for isolating target molecules and for performing amplification |
US5403711A (en) * | 1987-11-30 | 1995-04-04 | University Of Iowa Research Foundation | Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
US5708154A (en) * | 1989-02-24 | 1998-01-13 | City Of Hope | RNA-DNA hybrid molecules of nucleic acid |
US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
US6872816B1 (en) | 1996-01-24 | 2005-03-29 | Third Wave Technologies, Inc. | Nucleic acid detection kits |
US5994069A (en) * | 1996-01-24 | 1999-11-30 | Third Wave Technologies, Inc. | Detection of nucleic acids by multiple sequential invasive cleavages |
US5846717A (en) * | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US5213669A (en) * | 1992-01-31 | 1993-05-25 | Beckman Instruments, Inc. | Capillary column containing a dynamically cross-linked composition and method of use |
US5470705A (en) * | 1992-04-03 | 1995-11-28 | Applied Biosystems, Inc. | Probe composition containing a binding domain and polymer chain and methods of use |
ATE173767T1 (en) * | 1992-04-03 | 1998-12-15 | Perkin Elmer Corp | SAMPLES COMPOSITION AND METHODS |
US20060257885A1 (en) * | 1993-01-05 | 2006-11-16 | Gelfand David H | Homogeneous assay system |
WO1995000665A1 (en) * | 1993-06-17 | 1995-01-05 | The Research Foundation Of State University Of New York | Thermodynamics, design, and use of nucleic acid sequences |
AU7208394A (en) * | 1993-06-17 | 1995-01-17 | Research Foundation Of The State University Of New York, The | Improved nucleic acid reactions |
US6027884A (en) * | 1993-06-17 | 2000-02-22 | The Research Foundation Of The State University Of New York | Thermodynamics, design, and use of nucleic acid sequences |
EP0708840A1 (en) * | 1993-06-17 | 1996-05-01 | ID Biomedical Corporation | Improved methods for detecting nucleic acid sequences |
AU692816B2 (en) * | 1993-07-19 | 1998-06-18 | Gen-Probe Incorporated | Oligonucleotide screening assay |
US6071699A (en) | 1996-06-07 | 2000-06-06 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US6787304B1 (en) | 1994-12-28 | 2004-09-07 | Georgetown University | Fluorometric assay for detecting nucleic acid cleavage |
US20030165908A1 (en) * | 1994-12-30 | 2003-09-04 | Georgetown University | Fluorometric assay for detecting nucleic acid cleavage |
US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
US5656430A (en) * | 1995-06-07 | 1997-08-12 | Trevigen, Inc. | Oscillating signal amplifier for nucleic acid detection |
US5763178A (en) * | 1995-06-07 | 1998-06-09 | Trevigen, Inc. | Oscillating signal amplifier for nucleic acid detection |
FR2737223B1 (en) * | 1995-07-24 | 1997-09-12 | Bio Merieux | METHOD OF AMPLIFYING NUCLEIC ACID SEQUENCES BY MOVEMENT USING CHIMERIC PRIMERS |
US6248555B1 (en) * | 1995-08-31 | 2001-06-19 | The General Hospital Corporation | Genetic alterations related to familial alzheimer's disease |
US5747255A (en) * | 1995-09-29 | 1998-05-05 | Lynx Therapeutics, Inc. | Polynucleotide detection by isothermal amplification using cleavable oligonucleotides |
US5922535A (en) * | 1995-11-07 | 1999-07-13 | Huo; Li | Identifying sequence differences in nucleic acid populations |
US6706471B1 (en) | 1996-01-24 | 2004-03-16 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US6913881B1 (en) | 1996-01-24 | 2005-07-05 | Third Wave Technologies, Inc. | Methods and compositions for detecting target sequences |
US6875572B2 (en) | 1996-01-24 | 2005-04-05 | Third Wave Technologies, Inc. | Nucleic acid detection assays |
US7527928B2 (en) * | 1996-11-29 | 2009-05-05 | Third Wave Technologies, Inc. | Reactions on a solid surface |
US7122364B1 (en) * | 1998-03-24 | 2006-10-17 | Third Wave Technologies, Inc. | FEN endonucleases |
US20080160524A1 (en) * | 1996-01-24 | 2008-07-03 | Third Wave Technologies, Inc. | Methods and Compositions for Detecting Target Sequences |
US7195871B2 (en) * | 1996-01-24 | 2007-03-27 | Third Wave Technologies, Inc | Methods and compositions for detecting target sequences |
US7432048B2 (en) * | 1996-11-29 | 2008-10-07 | Third Wave Technologies, Inc. | Reactions on a solid surface |
US6090606A (en) * | 1996-01-24 | 2000-07-18 | Third Wave Technologies, Inc. | Cleavage agents |
US5985557A (en) | 1996-01-24 | 1999-11-16 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
US5955268A (en) * | 1996-04-26 | 1999-09-21 | Abbott Laboratories | Method and reagent for detecting multiple nucleic acid sequences in a test sample |
US6780982B2 (en) | 1996-07-12 | 2004-08-24 | Third Wave Technologies, Inc. | Charge tags and the separation of nucleic acid molecules |
US5858665A (en) * | 1996-07-25 | 1999-01-12 | Navix, Inc. | Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
US5853990A (en) * | 1996-07-26 | 1998-12-29 | Edward E. Winger | Real time homogeneous nucleotide assay |
US7381525B1 (en) * | 1997-03-07 | 2008-06-03 | Clinical Micro Sensors, Inc. | AC/DC voltage apparatus for detection of nucleic acids |
US6096273A (en) * | 1996-11-05 | 2000-08-01 | Clinical Micro Sensors | Electrodes linked via conductive oligomers to nucleic acids |
CA2273204C (en) | 1996-11-29 | 2008-10-14 | Third Wave Technologies, Inc. | Fen-1 endonucleases, mixtures and cleavage methods |
US6309874B1 (en) | 1997-06-04 | 2001-10-30 | Karolinska Innovations Ab | Selection marker |
US6503709B1 (en) * | 1997-07-03 | 2003-01-07 | Id Biomedical Corporation | Methods for rapidly detecting methicillin resistant staphylococci |
US6136533A (en) * | 1997-07-03 | 2000-10-24 | Id Biomedical | Additives for use in cycling probe reactions |
US6274316B1 (en) * | 1997-07-03 | 2001-08-14 | Id Biomedical Corporation | Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions |
CA2306138A1 (en) * | 1997-10-31 | 1999-05-14 | Peter John Zanzucchi | Method for enhancing fluorescence |
US8182991B1 (en) | 1997-11-26 | 2012-05-22 | Third Wave Technologies, Inc. | FEN-1 endonucleases, mixtures and cleavage methods |
US20020177144A1 (en) * | 1997-12-30 | 2002-11-28 | Jose Remacle | Detection and/or quantification method of a target molecule by a binding with a capture molecule fixed on the surface of a disc |
US20050244954A1 (en) * | 1998-06-23 | 2005-11-03 | Blackburn Gary F | Binding acceleration techniques for the detection of analytes |
ATE250784T1 (en) * | 1998-11-27 | 2003-10-15 | Synaptics Uk Ltd | POSITION SENSOR |
US6420115B1 (en) | 1999-12-21 | 2002-07-16 | Ingeneus Corporation | Cation mediated triplex hybridization assay |
US6858390B2 (en) | 1998-12-31 | 2005-02-22 | Ingeneus Corporation | Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
US6403313B1 (en) | 1999-12-21 | 2002-06-11 | Ingeneus Corporation | Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators |
US6656692B2 (en) | 1999-12-21 | 2003-12-02 | Ingeneus Corporation | Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
AU4476900A (en) | 1999-04-20 | 2000-11-02 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US20060275782A1 (en) | 1999-04-20 | 2006-12-07 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US20030207295A1 (en) * | 1999-04-20 | 2003-11-06 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US20030096321A1 (en) * | 1999-05-19 | 2003-05-22 | Jose Remacle | Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips |
US8481268B2 (en) | 1999-05-21 | 2013-07-09 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US8080380B2 (en) * | 1999-05-21 | 2011-12-20 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
CA2380258C (en) | 1999-07-26 | 2008-07-15 | Clinical Micro Sensors, Inc. | Sequence determination of nucleic acids using electronic detection |
US6692918B2 (en) | 1999-09-13 | 2004-02-17 | Nugen Technologies, Inc. | Methods and compositions for linear isothermal amplification of polynucleotide sequences |
US6911536B1 (en) | 1999-12-21 | 2005-06-28 | Ingeneus Corporation | Triplex and quadruplex catalytic hybridization |
US7052844B2 (en) * | 1999-12-21 | 2006-05-30 | Ingeneus, Inc. | Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism |
US7309569B2 (en) | 1999-12-21 | 2007-12-18 | Ingeneus, Inc. | Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
US6927027B2 (en) | 1999-12-21 | 2005-08-09 | Ingeneus Corporation | Nucleic acid multiplex formation |
US6924108B2 (en) | 1999-12-21 | 2005-08-02 | Ingeneus Corporation | Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues |
US7220541B2 (en) * | 2000-01-24 | 2007-05-22 | Ingeneus, Inc. | Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
US20030170659A1 (en) * | 2000-01-24 | 2003-09-11 | Ingeneus Corporation | Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding |
US6982147B2 (en) * | 2000-01-24 | 2006-01-03 | Ingeneus Corporation | Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions |
US6613524B1 (en) * | 2000-01-24 | 2003-09-02 | Ingeneus Corporation | Amperometric affinity assay and electrically stimulated complexes of nucleic acids |
US8076063B2 (en) * | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
US20050214825A1 (en) * | 2000-02-07 | 2005-09-29 | John Stuelpnagel | Multiplex sample analysis on universal arrays |
US7582420B2 (en) * | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7611869B2 (en) * | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
US7955794B2 (en) * | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7829313B2 (en) * | 2000-03-24 | 2010-11-09 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
US7875442B2 (en) * | 2000-03-24 | 2011-01-25 | Eppendorf Array Technologies | Identification and quantification of a plurality of biological (micro)organisms or their components |
US7846733B2 (en) * | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
JP2004513617A (en) * | 2000-06-26 | 2004-05-13 | ニューゲン テクノロジーズ, インコーポレイテッド | Methods and compositions for transcription-based nucleic acid amplification |
EP1366192B8 (en) * | 2000-10-24 | 2008-10-29 | The Board of Trustees of the Leland Stanford Junior University | Direct multiplex characterization of genomic dna |
WO2002070755A2 (en) * | 2000-11-15 | 2002-09-12 | Third Wave Technologies, Inc. | Fen endonucleases |
AU2002228974A1 (en) | 2000-12-13 | 2002-06-24 | Nugen Technologies, Inc | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
JP2005508135A (en) * | 2001-03-09 | 2005-03-31 | ニューゲン テクノロジーズ, インコーポレイテッド | Methods and compositions for amplification of RNA sequences |
MXPA02012739A (en) * | 2001-03-09 | 2004-04-20 | Nugen Technologies Inc | Methods and compositions for amplification of rna sequences. |
US20030092157A1 (en) * | 2001-03-16 | 2003-05-15 | Hayden Michael R. | Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels |
DE10117857B4 (en) * | 2001-04-10 | 2005-03-10 | Clondiag Chip Tech Gmbh | Method for detecting molecular interactions on probe arrays |
WO2002090600A2 (en) | 2001-05-08 | 2002-11-14 | Darwin Molecular Corporation | A method for regulating immune function in primates using the foxp3 protein |
AU2002305019A1 (en) * | 2001-05-25 | 2002-12-09 | University Of British Columbia | Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels |
AU2002327236A1 (en) | 2001-07-12 | 2003-01-29 | Illumina, Inc. | Multiplex nucleic acid reactions |
US20030082590A1 (en) * | 2001-07-15 | 2003-05-01 | Keck Graduate Institute | Exponential nucleic acid amplification using nicking endonucleases |
US6884619B2 (en) | 2001-07-17 | 2005-04-26 | Yale University | Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
GB2378245A (en) | 2001-08-03 | 2003-02-05 | Mats Nilsson | Nucleic acid amplification method |
US7122314B2 (en) * | 2002-01-30 | 2006-10-17 | Id Biomedical Corporation | Methods for detecting vancomycin-resistant microorganisms and compositions therefor |
EP1573056A4 (en) * | 2002-05-17 | 2007-11-28 | Nugen Technologies Inc | Methods for fragmentation, labeling and immobilization of nucleic acids |
US20040011650A1 (en) * | 2002-07-22 | 2004-01-22 | Frederic Zenhausern | Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
WO2004013606A2 (en) * | 2002-08-02 | 2004-02-12 | Stratatech Corporation | Species specific dna detection |
WO2004018626A2 (en) * | 2002-08-21 | 2004-03-04 | Epoch Biosciences, Inc. | Abasic site endonuclease assay |
US7803536B2 (en) * | 2002-09-20 | 2010-09-28 | Integrated Dna Technologies, Inc. | Methods of detecting fluorescence with anthraquinone quencher dyes |
US20040259105A1 (en) * | 2002-10-03 | 2004-12-23 | Jian-Bing Fan | Multiplex nucleic acid analysis using archived or fixed samples |
EP1585824A4 (en) | 2002-11-21 | 2008-01-02 | Epict Technologies | Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
US8206904B2 (en) * | 2002-12-18 | 2012-06-26 | Third Wave Technologies, Inc. | Detection of nucleic acids |
ATE525469T1 (en) | 2002-12-18 | 2011-10-15 | Third Wave Tech Inc | DETECTION OF SMALL NUCLEIC ACIDS |
US7297780B2 (en) | 2003-01-06 | 2007-11-20 | Third Wave Technologies, Inc. | Reactive functional groups for preparation of modified nucleic acid |
US6943768B2 (en) | 2003-02-21 | 2005-09-13 | Xtellus Inc. | Thermal control system for liquid crystal cell |
EP1613778B1 (en) * | 2003-04-14 | 2014-11-26 | Nugen Technologies, Inc. | Global amplification using a randomly primed composite primer |
WO2005001129A2 (en) * | 2003-06-06 | 2005-01-06 | Applera Corporation | Mobility cassettes |
US20040259100A1 (en) | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
WO2005019469A2 (en) * | 2003-08-11 | 2005-03-03 | Research Foundation Of Cuny | Rna detection and quantitation |
US20050048501A1 (en) * | 2003-09-02 | 2005-03-03 | Corn Robert Marcus | Method and apparatus for detection or identification of DNA |
US7354706B2 (en) * | 2003-09-09 | 2008-04-08 | The Regents Of The University Of Colorado, A Body Corporate | Use of photopolymerization for amplification and detection of a molecular recognition event |
US20090163375A1 (en) | 2003-09-09 | 2009-06-25 | Bowman Christopher N | Use of Photopolymerization for Amplification and Detection of a Molecular Recognition Event |
WO2005049849A2 (en) | 2003-11-14 | 2005-06-02 | Integrated Dna Technologies, Inc. | Fluorescence quenching azo dyes, their methods of preparation and use |
KR101041106B1 (en) * | 2003-11-25 | 2011-06-13 | 한면기 | Novel realtime detection of nucleic acids and proteins |
US20050136414A1 (en) * | 2003-12-23 | 2005-06-23 | Kevin Gunderson | Methods and compositions for making locus-specific arrays |
EP1711591A4 (en) * | 2003-12-29 | 2010-04-28 | Nugen Technologies Inc | Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
EP1574583A1 (en) * | 2004-03-10 | 2005-09-14 | Roche Diagnostics GmbH | Methods for isolation of bacteria from biological samples |
US7462451B2 (en) * | 2004-04-26 | 2008-12-09 | Third Wave Technologies, Inc. | Compositions for modifying nucleic acids |
AU2005250432B2 (en) | 2004-05-28 | 2011-09-15 | Asuragen, Inc. | Methods and compositions involving microRNA |
US20060078894A1 (en) * | 2004-10-12 | 2006-04-13 | Winkler Matthew M | Methods and compositions for analyzing nucleic acids |
ES2534304T3 (en) | 2004-11-12 | 2015-04-21 | Asuragen, Inc. | Procedures and compositions involving miRNA and miRNA inhibitor molecules |
US20080311568A1 (en) * | 2004-12-13 | 2008-12-18 | Autogenomics, Inc. | Compositions and Methods for Nucleic Acid Analysis of Sequences with Insertions or Deletions |
EP2239342A3 (en) | 2005-02-01 | 2010-11-03 | AB Advanced Genetic Analysis Corporation | Reagents, methods and libraries for bead-based sequencing |
AU2006235364A1 (en) | 2005-04-08 | 2006-10-19 | Marina Biotech, Inc. | RNAi therapeutic for respiratory virus infection |
US20070213293A1 (en) * | 2005-04-08 | 2007-09-13 | Nastech Pharmaceutical Company Inc. | Rnai therapeutic for respiratory virus infection |
CA2601554A1 (en) | 2005-05-20 | 2006-11-30 | Integrated Dna Technologies, Inc. | Compounds and methods for labeling oligonucleotides |
US7666584B2 (en) * | 2005-09-01 | 2010-02-23 | Philadelphia Health & Education Coporation | Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer |
WO2007030759A2 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
US20070207455A1 (en) * | 2005-11-17 | 2007-09-06 | Third Wave Technologies, Inc. | Compositions and methods for detecting an HCV-1 subtype |
US7981606B2 (en) * | 2005-12-21 | 2011-07-19 | Roche Molecular Systems, Inc. | Control for nucleic acid testing |
KR100652903B1 (en) * | 2005-12-21 | 2006-12-04 | 한국과학기술연구원 | Manufacturing method of dehumidifying agent having superabsorbing polymer and manufacturing apparatus thereof |
AU2007237909A1 (en) * | 2006-04-19 | 2007-10-25 | Applied Biosystems, Llc. | Reagents, methods, and libraries for gel-free bead-based sequencing |
US7674924B2 (en) * | 2006-05-22 | 2010-03-09 | Third Wave Technologies, Inc. | Compositions, probes, and conjugates and uses thereof |
US20080125333A1 (en) * | 2006-05-31 | 2008-05-29 | Antara Biosciences Inc. | Devices and kits for detecting one or more target agents |
CN101541975B (en) | 2006-06-01 | 2013-04-03 | 第三次浪潮技术公司 | Detection of nucleic acids |
EP2038429B1 (en) * | 2006-06-30 | 2013-08-21 | Nugen Technologies, Inc. | Methods for fragmentation and labeling of nucleic acids |
US20080026394A1 (en) * | 2006-07-11 | 2008-01-31 | Antara Biosciences Inc. | Methods of detecting one or more cancer markers |
US7501254B2 (en) * | 2006-07-20 | 2009-03-10 | Ghc Technologies, Inc. | Methods and compositions for amplification and capture of nucleic acid sequences |
NZ548731A (en) * | 2006-07-24 | 2008-12-24 | Zygem Corp Ltd | Isothermal detection methods and uses thereof |
WO2008036776A2 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
US20080131878A1 (en) * | 2006-12-05 | 2008-06-05 | Asuragen, Inc. | Compositions and Methods for the Detection of Small RNA |
DK2104737T3 (en) * | 2006-12-08 | 2013-05-27 | Asuragen Inc | Functions and Purposes of Easy-7 Micro-RNAs |
AU2007333106A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | miR-20 regulated genes and pathways as targets for therapeutic intervention |
CN101622349A (en) * | 2006-12-08 | 2010-01-06 | 奥斯瑞根公司 | miR-20 regulated genes and pathways as targets for therapeutic intervention |
WO2008073920A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
US20090175827A1 (en) * | 2006-12-29 | 2009-07-09 | Byrom Mike W | miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
CN101801419A (en) * | 2007-06-08 | 2010-08-11 | 米尔纳疗法公司 | Gene and path as the miR-34 regulation and control for the treatment of the target of intervening |
GB0713183D0 (en) * | 2007-07-06 | 2007-08-15 | King S College London | Method |
WO2009033156A2 (en) * | 2007-09-07 | 2009-03-12 | Third Wave Technologies, Inc. | Methods and applications for target quantification |
US8361714B2 (en) | 2007-09-14 | 2013-01-29 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
US20090186015A1 (en) * | 2007-10-18 | 2009-07-23 | Latham Gary J | Micrornas differentially expressed in lung diseases and uses thereof |
US20090137405A1 (en) * | 2007-11-16 | 2009-05-28 | Christopher Bowman | Detection of nucleic acid biomarkers using polymerization-based amplification |
WO2009070805A2 (en) * | 2007-12-01 | 2009-06-04 | Asuragen, Inc. | Mir-124 regulated genes and pathways as targets for therapeutic intervention |
WO2009086156A2 (en) * | 2007-12-21 | 2009-07-09 | Asuragen, Inc. | Mir-10 regulated genes and pathways as targets for therapeutic intervention |
WO2009133473A2 (en) * | 2008-01-08 | 2009-11-05 | Zygem Corporation Limited | Isothermal detection methods and uses thereof |
EP2260110B1 (en) * | 2008-02-08 | 2014-11-12 | Asuragen, INC. | miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS |
US20090203531A1 (en) * | 2008-02-12 | 2009-08-13 | Nurith Kurn | Method for Archiving and Clonal Expansion |
EP2274448B1 (en) * | 2008-03-15 | 2013-09-18 | Hologic, Inc. | Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
WO2009117698A2 (en) | 2008-03-21 | 2009-09-24 | Nugen Technologies, Inc. | Methods of rna amplification in the presence of dna |
US20090253780A1 (en) * | 2008-03-26 | 2009-10-08 | Fumitaka Takeshita | COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER |
US20090258928A1 (en) * | 2008-04-08 | 2009-10-15 | Asuragen, Inc. | Methods and compositions for diagnosing and modulating human papillomavirus (hpv) |
JP2009268665A (en) * | 2008-05-07 | 2009-11-19 | Canon Inc | Inhalation device |
EP2285960B1 (en) | 2008-05-08 | 2015-07-08 | Asuragen, INC. | Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis |
US8208909B2 (en) | 2008-06-02 | 2012-06-26 | West Corporation | System, apparatus and method for availing a mobile call of address information |
WO2010030716A1 (en) * | 2008-09-10 | 2010-03-18 | Igor Kutyavin | Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v |
WO2010056737A2 (en) * | 2008-11-11 | 2010-05-20 | Mirna Therapeutics, Inc. | Methods and compositions involving mirnas in cancer stem cells |
US20110091931A1 (en) * | 2009-04-24 | 2011-04-21 | Colby Pharmaceutical Company | Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other Pathophysiologies |
US9914963B2 (en) | 2009-09-28 | 2018-03-13 | Igor Kutyavin | Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes |
WO2011059686A2 (en) | 2009-10-29 | 2011-05-19 | Wisconsin Alumni Research Foundation | Detection of b-cell activating factor as a biomaker for antibody mediated rejection in transplant recipients |
US8394589B2 (en) | 2009-12-21 | 2013-03-12 | Northwestern University | Methods for diagnosing scapuloperoneal spinal muscular atrophy or Charcot-Marie-Tooth disease type 2C by detecting mutations in TRPV4 |
WO2011087707A1 (en) | 2009-12-22 | 2011-07-21 | Elitech Holding B.V. | Hypertheromostable endonuclease iv substrate probe |
EP2369325A1 (en) | 2010-03-12 | 2011-09-28 | Eppendorf Ag | Array analysis for online detection |
US20120108799A1 (en) | 2010-09-07 | 2012-05-03 | Integrated Dna Technologies, Inc. | Modifications for Antisense Compounds |
AU2011230496B2 (en) | 2010-03-26 | 2015-09-17 | Integrated Dna Technologies, Inc. | Methods for enhancing nucleic acid hybridization |
US9506057B2 (en) | 2010-03-26 | 2016-11-29 | Integrated Dna Technologies, Inc. | Modifications for antisense compounds |
US20120052502A1 (en) * | 2010-08-30 | 2012-03-01 | Samsung Techwin Co., Ltd. | Real-time pcr detection using stabilized probes |
US10233501B2 (en) | 2010-10-19 | 2019-03-19 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
US10093981B2 (en) | 2010-10-19 | 2018-10-09 | Northwestern University | Compositions and methods for identifying depressive disorders |
US20150218639A1 (en) | 2014-01-17 | 2015-08-06 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
US20150225792A1 (en) | 2014-01-17 | 2015-08-13 | Northwestern University | Compositions and methods for identifying depressive disorders |
CN103703173A (en) | 2011-02-02 | 2014-04-02 | 精密科学公司 | Digital sequence analysis of dna methylation |
CA2835345C (en) | 2011-05-12 | 2021-03-09 | Exact Sciences Corporation | Isolation of nucleic acids |
US8993341B2 (en) | 2011-05-12 | 2015-03-31 | Exact Sciences Corporation | Removal of PCR inhibitors |
US8808990B2 (en) | 2011-05-12 | 2014-08-19 | Exact Sciences Corporation | Serial isolation of multiple DNA targets from stool |
US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
CA2852949A1 (en) | 2011-10-19 | 2013-04-25 | Nugen Technologies, Inc. | Compositions and methods for directional nucleic acid amplification and sequencing |
WO2013096798A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Amplification of a sequence from a ribonucleic acid |
EP3578697B1 (en) | 2012-01-26 | 2024-03-06 | Tecan Genomics, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
JP6466173B2 (en) | 2012-02-14 | 2019-02-06 | ヴェラ オペレーションズ ユーエスエー,インコーポレーテッド | Isothermal amplification using block primers |
AU2013205064B2 (en) | 2012-06-04 | 2015-07-30 | Gen-Probe Incorporated | Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid |
US9957549B2 (en) | 2012-06-18 | 2018-05-01 | Nugen Technologies, Inc. | Compositions and methods for negative selection of non-desired nucleic acid sequences |
US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
US9212392B2 (en) | 2012-09-25 | 2015-12-15 | Exact Sciences Corporation | Normalization of polymerase activity |
EP2971179B1 (en) | 2013-03-14 | 2019-01-09 | Mayo Foundation for Medical Education and Research | Detecting neoplasm |
EP2971130A4 (en) | 2013-03-15 | 2016-10-05 | Nugen Technologies Inc | Sequential sequencing |
WO2015042446A2 (en) | 2013-09-20 | 2015-03-26 | The Regents Of The University Of Michigan | Compositions and methods for the analysis of radiosensitivity |
WO2015066695A1 (en) | 2013-11-04 | 2015-05-07 | Exact Sciences Corporation | Multiple-control calibrators for dna quantitation |
CN105849264B (en) | 2013-11-13 | 2019-09-27 | 纽亘技术公司 | For identifying the composition and method that repeat sequencing reading |
US9909181B2 (en) | 2013-12-13 | 2018-03-06 | Northwestern University | Biomarkers for post-traumatic stress states |
EP3084004A4 (en) | 2013-12-19 | 2017-08-16 | Exact Sciences Corporation | Synthetic nucleic acid control molecules |
US9745614B2 (en) | 2014-02-28 | 2017-08-29 | Nugen Technologies, Inc. | Reduced representation bisulfite sequencing with diversity adaptors |
US10301680B2 (en) | 2014-03-31 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasm |
CN113981057A (en) | 2014-12-12 | 2022-01-28 | 精密科学公司 | Compositions and methods for performing methylation detection assays |
US10011878B2 (en) | 2014-12-12 | 2018-07-03 | Exact Sciences Development Company | Compositions and methods for performing methylation detection assays |
EP3274440A4 (en) | 2015-03-27 | 2019-03-06 | Exact Sciences Corporation | Detecting esophageal disorders |
GB201513128D0 (en) * | 2015-07-24 | 2015-09-09 | Sense Biodetection Ltd | Nucleic acid detection method |
AU2016343937B2 (en) | 2015-10-30 | 2023-01-19 | Exact Sciences Corporation | Multiplex amplification detection assay and isolation and detection of DNA from plasma |
US20170321286A1 (en) | 2016-05-05 | 2017-11-09 | Exact Sciences Corporation | Detection of lung neoplasia by amplification of rna sequences |
WO2017192221A1 (en) | 2016-05-05 | 2017-11-09 | Exact Sciences Corporation | Detection of lung neoplasia by analysis of methylated dna |
CA3029838A1 (en) | 2016-07-19 | 2018-01-25 | Exact Sciences Development Company, Llc | Nucleic acid control molecules from non-human organisms |
US11345949B2 (en) | 2016-07-19 | 2022-05-31 | Exact Sciences Corporation | Methylated control DNA |
CN116064795A (en) | 2016-09-02 | 2023-05-05 | 梅约医学教育与研究基金会 | Methods and kits for determining methylation status of differentially methylated regions |
GB201701262D0 (en) | 2017-01-25 | 2017-03-08 | Sense Biodetection Ltd | Nucleic acid detection method |
US11118228B2 (en) | 2017-01-27 | 2021-09-14 | Exact Sciences Development Company, Llc | Detection of colon neoplasia by analysis of methylated DNA |
US10995104B2 (en) | 2017-05-30 | 2021-05-04 | Roche Molecular System, Inc. | Catalysts for reversing formaldehyde adducts and crosslinks |
US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
AU2019247652A1 (en) | 2018-04-02 | 2020-10-15 | Enumera Molecular, Inc. | Methods, systems, and compositions for counting nucleic acid molecules |
US11408030B2 (en) | 2018-09-10 | 2022-08-09 | Andy Madrid | Test for detecting Alzheimer's disease |
WO2020206170A1 (en) | 2019-04-02 | 2020-10-08 | Progenity, Inc. | Methods, systems, and compositions for counting nucleic acid molecules |
CN114729399A (en) | 2019-10-31 | 2022-07-08 | 梅约医学教育与研究基金会 | Detection of ovarian cancer |
SG10201910254YA (en) | 2019-11-04 | 2021-06-29 | Denka Company Ltd | Nucleic Acid Detection Method Using Lamp And Probe Detection |
US20230357852A1 (en) | 2020-08-19 | 2023-11-09 | Mayo Foundation For Medical Education And Research | Detecting non-hodgkin lymphoma |
EP4214243A1 (en) | 2020-09-21 | 2023-07-26 | Progenity, Inc. | Compositions and methods for isolation of cell-free dna |
WO2023011660A1 (en) | 2021-08-06 | 2023-02-09 | Sansure Biotech Inc. | Compositions for liquefying a viscous biological sample, combination products, liquefying agents, and kits thereof, and methods and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0212067A1 (en) * | 1985-07-17 | 1987-03-04 | AlliedSignal Inc. | Homegeneous polynucleotide displacement assay method, kit and reagent complex |
EP0227976A2 (en) * | 1985-12-05 | 1987-07-08 | Meiogenics, Inc. | Molecules useful for detecting nucleic acid sequences |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820630A (en) * | 1984-11-23 | 1989-04-11 | Digene Diagnostics, Incorporated | Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels |
DE68911648T2 (en) * | 1988-03-24 | 1994-06-23 | Univ Iowa Res Found | CATALYTIC HYBRIDIZING SYSTEMS FOR DETECTING NUCLEIC ACID SEQUENCES BASED ON THEIR ACTIVITY AS COFACTORS IN CATALYTIC REACTIONS IN WHICH A COMPLEMENTARY, MARKED NUCLEIC ACID SAMPLE IS SPLIT. |
-
1988
- 1988-04-29 US US07/187,814 patent/US5011769A/en not_active Expired - Lifetime
-
1989
- 1989-04-24 CA CA000597529A patent/CA1341495C/en not_active Expired - Fee Related
- 1989-04-28 WO PCT/US1989/001825 patent/WO1989010415A1/en not_active Application Discontinuation
- 1989-04-28 EP EP19890905902 patent/EP0365663A4/en not_active Withdrawn
- 1989-04-28 JP JP1505932A patent/JP2839608B2/en not_active Expired - Lifetime
- 1989-04-28 AU AU35697/89A patent/AU3569789A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0212067A1 (en) * | 1985-07-17 | 1987-03-04 | AlliedSignal Inc. | Homegeneous polynucleotide displacement assay method, kit and reagent complex |
EP0227976A2 (en) * | 1985-12-05 | 1987-07-08 | Meiogenics, Inc. | Molecules useful for detecting nucleic acid sequences |
Non-Patent Citations (1)
Title |
---|
See also references of EP0365663A4 * |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792607A (en) * | 1990-01-26 | 1998-08-11 | Abbott Laboratories | Method and kits for amplifying target nucleic acids applicable to both polymerase and ligase chain reactions |
EP0439182A3 (en) * | 1990-01-26 | 1991-10-16 | Abbott Laboratories | Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions |
EP0439182A2 (en) * | 1990-01-26 | 1991-07-31 | Abbott Laboratories | Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions |
WO1991017264A1 (en) * | 1990-05-02 | 1991-11-14 | Imperial Chemical Industries Plc | Assay for specific nucleic acid sequences |
EP0455517A1 (en) * | 1990-05-04 | 1991-11-06 | Oncor, Inc. | Restriction amplification assay |
EP0578138A2 (en) * | 1992-07-10 | 1994-01-12 | Hitachi, Ltd. | Gene-detecting method |
EP0578138A3 (en) * | 1992-07-10 | 1994-10-26 | Hitachi Ltd | Gene-detecting method. |
FR2697851A1 (en) * | 1992-11-10 | 1994-05-13 | Bio Merieux | Detecting target nucleic acid by restriction enzyme amplification |
EP0599338A2 (en) * | 1992-11-27 | 1994-06-01 | Canon Kabushiki Kaisha | Method for detecting target nucleic acid |
US5939256A (en) * | 1992-11-27 | 1999-08-17 | Canon Kabushiki Kaisha | Detection of nucleic acid hybrid variation which interacts with double helix or with second reagent through double helix by charge transfer and probe for hybridizing with target nucleic acid |
US5705346A (en) * | 1992-11-27 | 1998-01-06 | Canon Kabushiki Kaisha | Method for detecting a target nucleic acid by using an interaction of two kinds of reagents |
EP0599338A3 (en) * | 1992-11-27 | 1995-06-21 | Canon Kk | Method for detecting target nucleic acid. |
US6022961A (en) * | 1992-12-21 | 2000-02-08 | Canon Kabushiki Kaisha | Fluorescent stain containing pyrylium salt and fluorescent staining method of biological sample |
US5624798A (en) * | 1992-12-21 | 1997-04-29 | Canon Kabushiki Kaisha | Detection method of nucleic acid by use of fluorescent pyrylium stain in intercalation into nucleic acids |
EP0711361A4 (en) * | 1993-06-04 | 1998-04-15 | Third Wave Tech Inc | 5' nucleases derived from thermostable dna polymerase |
EP1505160A3 (en) * | 1993-06-04 | 2005-05-04 | Third Wave Technologies, Inc. | 5'nucleases derived from thermostable DNA polymerase |
EP1505160A2 (en) * | 1993-06-04 | 2005-02-09 | Third Wave Technologies, Inc. | 5'nucleases derived from thermostable DNA polymerase |
EP0711361A1 (en) * | 1993-06-04 | 1996-05-15 | Third Wave Technologies, Inc. | 5' nucleases derived from thermostable dna polymerase |
WO1995005480A3 (en) * | 1993-08-18 | 1995-03-23 | Id Biomedical Corp | Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules |
WO1995005480A2 (en) * | 1993-08-18 | 1995-02-23 | Id Biomedical Corporation | Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules |
US5731146A (en) * | 1993-08-18 | 1998-03-24 | Id Biomedical Corporation | Compositions and methods for detecting target nucleic acid sequences utilizing adjacent sequence-enzyme molecules |
US5601978A (en) * | 1993-09-03 | 1997-02-11 | Abbott Laboratories | Oligonucleotides and methods for the detection of chlamydia trachomatis |
WO1995006756A2 (en) * | 1993-09-03 | 1995-03-09 | Abbott Laboratories | OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
US5846785A (en) * | 1993-09-03 | 1998-12-08 | Abbott Laboratories | Oligonucleotides specific for the MOMP gene sequence and methods for the detection of Chlamydia trachomatis |
US5756298A (en) * | 1993-09-03 | 1998-05-26 | Abbott Laboratories | Oligonucleotides and methods for the detection of Chlamydia trachomatis |
WO1995006756A3 (en) * | 1993-09-03 | 1995-05-04 | Abbott Lab | OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
US5670315A (en) * | 1993-09-13 | 1997-09-23 | Canon Kabushiki Kaisha | Nucleic acid determination employing pyryilium dye |
WO1995014106A3 (en) * | 1993-11-17 | 1995-08-24 | Id Biomedical Corp | Cycling probe cleavage detection of nucleic acid sequences |
WO1995014106A2 (en) * | 1993-11-17 | 1995-05-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
US5660988A (en) * | 1993-11-17 | 1997-08-26 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
US6242477B1 (en) | 1993-12-27 | 2001-06-05 | Canon Kabushiki Kaisha | Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
US6124342A (en) * | 1993-12-27 | 2000-09-26 | Canon Kk | Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |
US6156506A (en) * | 1994-05-26 | 2000-12-05 | Canon Kabushiki Kaisha | Method for detecting a target substance in a sample, utilizing pyrylium compound |
US5783392A (en) * | 1994-11-23 | 1998-07-21 | Boehringer Mannheim Gmbh | Method for the particularly sensitive detection of nucleic acids |
US6001610A (en) * | 1994-11-23 | 1999-12-14 | Roche Diagnostics, Gmbh | Method for the particularly sensitive detection of nucleic acids |
WO1996020287A2 (en) * | 1994-12-23 | 1996-07-04 | Behringwerke Aktiengesellschaft | Detection of nucleic acids by target-catalyzed product formation |
US6110677A (en) * | 1994-12-23 | 2000-08-29 | Dade Behring Marburg Gmbh | Oligonucleotide modification, signal amplification, and nucleic acid detection by target-catalyzed product formation |
US5792614A (en) * | 1994-12-23 | 1998-08-11 | Dade Behring Marburg Gmbh | Detection of nucleic acids by target-catalyzed product formation |
US6368803B1 (en) * | 1994-12-23 | 2002-04-09 | Dade Behring Inc. | Detection of nucleic acids by target-catalyzed formation |
US6121001A (en) * | 1994-12-23 | 2000-09-19 | Dade Behring Marburg Gmbh | Detection of nucleic acids by target-catalyzed product formation |
WO1996020287A3 (en) * | 1994-12-23 | 1996-09-06 | Behringwerke Ag | Detection of nucleic acids by target-catalyzed product formation |
US6297008B1 (en) | 1996-10-03 | 2001-10-02 | Canon Kabushiki Kaisha | Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
JP4644944B2 (en) * | 2001-01-30 | 2011-03-09 | ニプロ株式会社 | Target nucleic acid detection method and reagent therefor |
JP2002223761A (en) * | 2001-01-30 | 2002-08-13 | Nipro Corp | Method for detecting target nucleic acid and reagent therefor |
US7135291B2 (en) | 2001-02-15 | 2006-11-14 | Takara Bio Inc. | Method of detecting nucleotide polymorphism |
US6884586B2 (en) | 2001-07-15 | 2005-04-26 | Keck Graduate Institute | Methylation analysis using nicking agents |
US7112423B2 (en) | 2001-07-15 | 2006-09-26 | Keck Graduate Institute | Nucleic acid amplification using nicking agents |
US9562258B2 (en) | 2005-02-15 | 2017-02-07 | Georgetown University | Sequence-specific detection of nucleotide sequences |
WO2009085704A3 (en) * | 2007-12-26 | 2009-09-03 | Gen-Probe Incorporated | Compositions and methods to detect candida albicans nucleic acid |
US7595164B2 (en) | 2007-12-26 | 2009-09-29 | Gen-Probe Incorporated | Compositions and methods to detect Candida albicans nucleic acid |
US7670780B2 (en) | 2007-12-26 | 2010-03-02 | Gen-Probe Incorporated | Compositions and methods to detect Candida albicans nucleic acid |
US9109262B2 (en) | 2007-12-26 | 2015-08-18 | Gen-Probe Incorporated | Compositions and methods to detect Candida albicans nucleic acid |
US9109263B2 (en) | 2007-12-26 | 2015-08-18 | Gen-Probe Incorporated | Compositions to detect Candida albicans nucleic acid |
WO2013154138A1 (en) | 2012-04-11 | 2013-10-17 | 富士レビオ株式会社 | Method for detecting target nucleic acid using molecular beacon-type probe |
EP3907298A4 (en) * | 2020-02-28 | 2022-03-09 | Nuribio., Ltd. | Single nucleic acid for real-time detection of genetic variation of single target gene, and detection method using same |
Also Published As
Publication number | Publication date |
---|---|
US5011769A (en) | 1991-04-30 |
CA1341495C (en) | 2006-02-07 |
EP0365663A1 (en) | 1990-05-02 |
AU3569789A (en) | 1989-11-24 |
JPH02504110A (en) | 1990-11-29 |
JP2839608B2 (en) | 1998-12-16 |
EP0365663A4 (en) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5011769A (en) | Methods for detecting nucleic acid sequences | |
EP1129215B1 (en) | Ligation assembly and detection of polynucleotides on solid-support | |
JP2775346B2 (en) | Probe composition and method | |
EP1288313B1 (en) | System and method for assaying nucleic acid molecules | |
US5681943A (en) | Method for covalently linking adjacent oligonucleotides | |
JP2788034B2 (en) | Amplification method for polynucleotide assay | |
US7214783B2 (en) | Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases | |
EP1368489B1 (en) | Asynchronous primed pcr | |
EP0373956B1 (en) | Nucleotide probes | |
EP0227976A2 (en) | Molecules useful for detecting nucleic acid sequences | |
KR101041106B1 (en) | Novel realtime detection of nucleic acids and proteins | |
JPH07509365A (en) | Method for introducing a specific sequence into the 3' end of polynucleotides | |
WO1996041001A1 (en) | Method for analyzing a nucleotide sequence and kit therefore | |
JPH07143900A (en) | Polynucleotide for use in amplifying single primer and oligonucleotide containing phospho- thioate as primer in amplifying nucleic acid. | |
WO2008002920A2 (en) | Methods for generating target nucleic acid sequences | |
US5601976A (en) | Method for detecting target nucleic acid in specimen | |
JP2644419B2 (en) | Immobilization of nucleic acids | |
JPH08238100A (en) | Method for specifically detecting nucleic acid having prescribed sequence, and probe and kit used in the same method | |
JPH01500003A (en) | Polynucleotide probes on solid supports with photolabile binding | |
McGuire | Synthesis and studies of modified nucleotides and oligonucleotides | |
EP1412522A1 (en) | Amplifiable probe | |
Shaw | One-Step PCR Sequencing. Final Technical Progress Report for February 15, 1997-November 30, 2001 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU DK JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989905902 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989905902 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989905902 Country of ref document: EP |